https://www.selleckchem.com/pr....oducts/gf109203x.htm
Although transjugular intrahepatic portosystemic shunt (TIPS) is recommended for secondary prophylaxis of variceal bleeding if standard therapy fails and for patients with high risk of recurrent bleeding, no guidelines for the treatment of symptomatic portal hypertension in HCC patients are available. This study aimed to compare the efficacy and safety of TIPS with endoscopic + β-blocker for prevention of the rebleeding in such patients. 106 consecutive advanced HCC patients receiving tyrosine kinase inhibitor (TKI) who had been treat
Like
Comment
Share
